AVASTIN BIOLOGIC

  • enzene biosciences announces india launch of colorectal cancer drug bevacizumab

    Enzene Biosciences announces India launch of colorectal cancer drug Bevacizumab

    During the launch of Bevacizumab, a biosimilar of Avastin, Dr Himanshu Gadgil, CEO, Enzene Biosciences Ltd stated that one of the problems they were trying to solve was to disrupt the cost barriers in the biosimilars market because India has been developing biosimilars for quite some time but the affordability has remained a big concern.

    • Exclusive

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Download ETHealthworld App for Realtime updates

Seamless reading experience. Save your favourite.

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement